Valuation
- Market cap
- 56,840,000
- Revenue TTM
- $195,190,000
- Net income TTM
- $-9,380,000
- PE ratio
- 0.00
- Forward PE
- —
- Profit margin
- -4.81%
- Debt to equity
- 0.07
Trading
- Volume
- 371,357
- Avg volume
- 121,400
- Day's range
- $0.63 – $0.72
- Shares out
- 88,646,000
- Stochastic %K
- 18%
- Beta
- 1.29
- Analysts
- Strong Buy
- Price target
- $1.50
Company profile
CBAK Energy Technology Limited, together with its subsidiaries, manufactures, commercializes, and distributes lithium-ion and sodium-ion rechargeable batteries. The company operates through the CBAK and Hitrans segments. It develops and manufactures nickel-cobalt-manganese precursor materials and cathode materials. It also provides battery systems and integration solutions for electric vehicles and energy storage app...
Show more
CBAK Energy Technology Limited, together with its subsidiaries, manufactures, commercializes, and distributes lithium-ion and sodium-ion rechargeable batteries. The company operates through the CBAK and Hitrans segments. It develops and manufactures nickel-cobalt-manganese precursor materials and cathode materials. It also provides battery systems and integration solutions for electric vehicles and energy storage applications. Its products are used in electric cars, buses, hybrid vehicles, electric bicycles, tricycles, and other mobility applications, as well as in energy storage systems including residential supply and power supply applications. The company supports applications in logistics vehicles, commercial vehicles, and light electric mobility, and supplies battery solutions for both transportation and stationary energy storage use cases. CBAK Energy Technology Limited was founded in 2001 and is based in Dalian, China, and serves markets in China and international regions.
- Industry
- Electrical Equipment & Parts
- Sector
- Industrials
- Phone
- 86 41 1391 8596 8
- Website
- https://www.cbak.com.cn
- Address
- CBAK Industrial Park, Meigui Street Huayuankou Economic Zone, Dalian, China
Latest news
No headlines yet.